US/MR Bimodal Imaging-Guided Bio-Targeting Synergistic Agent for Tumor Therapy

References

• Kennedy JE. High-intensity focused ultrasound in the treatment of solid tumours. Nat Rev Cancer. 2005;5(4):321–327. doi:10.1038/nrc1591
   PubMed Web of Science ®Google Scholar
• Diana M, Schiraldi L, Liu YY, et al. High intensity focused ultrasound (HIFU) applied to hepato-bilio-pancreatic and the digestive system-current state of the art and future perspectives. Hepatobiliary Surg Nutr. 2016;5(4):329–344. doi:10.21037/hbsn.2015.11.03
   PubMed Web of Science ®Google Scholar
• Duc NM, Keserci B. Emerging clinical applications of high-intensity focused ultrasound. Diagn Interv Radiol. 2019;25(5):398–409. doi:10.5152/dir.2019.18556
   PubMed Web of Science ®Google Scholar
• Elhelf IAS, Albahar H, Shah U, et al. High intensity focused ultrasound: the fundamentals, clinical applications and research trends. Diagn Interv Imaging. 2018;99(6):349–359. doi:10.1016/j.diii.2018.03.001
   PubMed Web of Science ®Google Scholar
• Cheung TT, Ma KW, She WH. A review on radiofrequency, microwave and high-intensity focused ultrasound ablations for hepatocellular carcinoma with cirrhosis. Hepatobiliary Surg Nutr. 2021;10(2):193–209. doi:10.21037/hbsn.2020.03.11
   PubMed Web of Science ®Google Scholar
• Al-Bataineh O, Jenne J, Huber P. Clinical and future applications of high intensity focused ultrasound in cancer. Cancer Treat Rev. 2012;38(5):346–353. doi:10.1016/j.ctrv.2011.08.004
   PubMed Web of Science ®Google Scholar
• Tang H, Guo Y, Peng L, et al. In vivo targeted, responsive, and synergistic cancer nanotheranostics by magnetic resonance imaging-guided synergistic high-intensity focused ultrasound ablation and chemotherapy. ACS Appl Mater Interfaces. 2018;10(18):15428–15441. doi:10.1021/acsami.8b01967
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yong L, Luo Y, et al. Enhancement of HIFU ablation by sonosensitizer-loading liquid fluorocarbon nanoparticles with pre-targeting in a mouse model. Sci Rep. 2019;9(1):6982. doi:10.1038/s41598-019-43416-y
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen H, Sun Y, et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angewandte Chemie. 2011;50(52):12505–12509.
   Google Scholar
• Wang X, Chen H, Chen Y, et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater. 2012;24(6):785–791. doi:10.1002/adma.201104033
   PubMed Web of Science ®Google Scholar
• Sabuncu S, Yildirim A. Gas-stabilizing nanoparticles for ultrasound imaging and therapy of cancer. Nano Convergence. 2021;8(1):39. doi:10.1186/s40580-021-00287-2
   PubMed Web of Science ®Google Scholar
• Yildirim A, Chattaraj R, Blum NT, et al. Stable encapsulation of air in mesoporous silica nanoparticles: fluorocarbon-free nanoscale ultrasound contrast agents. Adv Healthcare Mater. 2016;5(11):1290–1298. doi:10.1002/adhm.201600030
   Web of Science ®Google Scholar
• Ma M, Xu H, Chen H, et al. A drug-perfluorocarbon nanoemulsion with an ultrathin silica coating for the synergistic effect of chemotherapy and ablation by high-intensity focused ultrasound. Adv Mater. 2014;26(43):7378–7385. doi:10.1002/adma.201402969
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang Z, Chen Y, et al. Microbubbles from gas-generating perfluorohexane nanoemulsions for targeted temperature-sensitive ultrasonography and synergistic HIFU ablation of tumors. Adv Mater. 2013;25(30):4123–4130. doi:10.1002/adma.201301655
   PubMed Web of Science ®Google Scholar
• Sharma N, Singhal M, Kumari RM, et al. Diosgenin loaded polymeric nanoparticles with potential anticancer efficacy. Biomolecules. 2020;10(12):1679. doi:10.3390/biom10121679
   PubMed Web of Science ®Google Scholar
• Kumari M, Sharma N, Manchanda R, et al. PGMD/curcumin nanoparticles for the treatment of breast cancer. Sci Rep. 2021;11(1):3824. doi:10.1038/s41598-021-81701-x
   PubMed Web of Science ®Google Scholar
• Prasad KS, Pillai RR, Shivamallu C, et al. Tumoricidal potential of novel Amino-1,10-phenanthroline derived imine ligands: chemical preparation, structure, and biological investigations. Molecules. 2020;25(12):2865. doi:10.3390/molecules25122865
   PubMed Web of Science ®Google Scholar
• Sharma N, Kumari RM, Gupta N, et al. Poly-(Lactic-co-Glycolic) acid nanoparticles for synergistic delivery of epirubicin and paclitaxel to human lung cancer cells. Molecules. 2020;25(18):4243. doi:10.3390/molecules25184243
   PubMed Web of Science ®Google Scholar
• Lee SH, Cho SY, Yoon Y, et al. Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice. Nature Microbiol. 2021;6(3):277–288. doi:10.1038/s41564-020-00831-6
   PubMed Web of Science ®Google Scholar
• Tang Y, Chen C, Jiang B, et al. Bifidobacterium bifidum-mediated specific delivery of nanoparticles for tumor therapy. Int J Nanomedicine. 2021;16:4643–4659. doi:10.2147/IJN.S315650
   PubMed Web of Science ®Google Scholar
• Liang K, Liu Q, Li P, et al. Genetically engineered Salmonella Typhimurium: recent advances in cancer therapy. Cancer Lett. 2019;448:168–181. doi:10.1016/j.canlet.2019.01.037
   PubMed Web of Science ®Google Scholar
• Wei B, Pan J, Yuan R, et al. Polarization of tumor-associated macrophages by nanoparticle-loaded escherichia coli combined with immunogenic cell death for cancer immunotherapy. Nano Lett. 2021;21(10):4231–4240. doi:10.1021/acs.nanolett.1c00209
   PubMed Web of Science ®Google Scholar
• Yang H, Jiang F, Ji X, et al. Genetically engineered bacterial protein nanoparticles for targeted cancer therapy. Int J Nanomedicine. 2021;16:105–117. doi:10.2147/IJN.S292432
   PubMed Web of Science ®Google Scholar
• Yazawa K, Fujimori M, Amano J, et al. Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors. Cancer Gene Ther. 2000;7(2):269–274. doi:10.1038/sj.cgt.7700122
   PubMed Web of Science ®Google Scholar
• Taniguchi S, Fujimori M, Sasaki T, et al. Targeting solid tumors with non-pathogenic obligate anaerobic bacteria. Cancer Sci. 2010;101(9):1925–1932. doi:10.1111/j.1349-7006.2010.01628.x
   PubMed Web of Science ®Google Scholar
• Gao X, Zou W, Jiang B, et al. Experimental study of retention on the combination of bifidobacterium with High-Intensity Focused Ultrasound (HIFU) synergistic substance in tumor tissues. Sci Rep. 2019;9(1):6423. doi:10.1038/s41598-019-42832-4
   PubMed Web of Science ®Google Scholar
• Wang Y, Chen C, Luo Y, et al. Experimental study of tumor therapy mediated by multimodal imaging based on a biological targeting synergistic agent. Int J Nanomedicine. 2020;15:1871–1888. doi:10.2147/IJN.S238398
   PubMed Web of Science ®Google Scholar
• Luo CH, Huang CT, Su CH, et al. Bacteria-mediated hypoxia-specific delivery of nanoparticles for tumors imaging and therapy. Nano Lett. 2016;16(6):3493–3499. doi:10.1021/acs.nanolett.6b00262
   PubMed Web of Science ®Google Scholar
• Lee SY, Jeon SI, Jung S, et al. Targeted multimodal imaging modalities. Adv Drug Deliv Rev. 2014;76:60–78. doi:10.1016/j.addr.2014.07.009
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang XY, Chen YL, et al. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy. Acta Biomater. 2018;80:308–326. doi:10.1016/j.actbio.2018.09.024
   PubMed Web of Science ®Google Scholar
• Ye S, Liu Y, Lu Y, et al. Cyclic RGD functionalized liposomes targeted to activated platelets for thrombosis dual-mode magnetic resonance imaging. J Mater Chem B. 2020;8(3):447–453. doi:10.1039/C9TB01834D
   PubMed Web of Science ®Google Scholar
• Jin M, Jin G, Kang L, et al. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes. Int J Nanomedicine. 2018;13:2405–2426. doi:10.2147/IJN.S161426
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4(2):145–160. doi:10.1038/nrd1632
   PubMed Web of Science ®Google Scholar
• Lamichhane N, Udayakumar TS, D’Souza WD, et al. Liposomes: clinical applications and potential for image-guided drug delivery. Molecules. 2018;23(2):288. doi:10.3390/molecules23020288
   PubMed Web of Science ®Google Scholar
• Farzin A, Etesami SA, Quint J, et al. Magnetic nanoparticles in cancer therapy and diagnosis. Adv Healthcare Mater. 2020;9(9):e1901058. doi:10.1002/adhm.201901058
   Web of Science ®Google Scholar
• Jahangirian H, Kalantari K, Izadiyan Z, et al. A review of small molecules and drug delivery applications using gold and iron nanoparticles. Int J Nanomedicine. 2019;14:1633–1657. doi:10.2147/IJN.S184723
   PubMed Web of Science ®Google Scholar
• Xiao S, Shi H, Zhang Y, et al. Bacteria-driven hypoxia targeting delivery of chemotherapeutic drug proving outcome of breast cancer. J Nanobiotechnology. 2022;20(1):178. doi:10.1186/s12951-022-01373-1
   PubMed Web of Science ®Google Scholar
• Xu D, Zou W, Luo Y, et al. Feasibility between bifidobacteria targeting and changes in the acoustic environment of tumor tissue for synergistic HIFU. Sci Rep. 2020;10(1):7772. doi:10.1038/s41598-020-64661-6
   PubMed Web of Science ®Google Scholar
• Zhou H, He Z, Wang C, et al. Intravenous administration is an effective and safe route for cancer gene therapy using the bifidobacterium-mediated recombinant HSV-1 thymidine kinase and ganciclovir. Int J Mol Sci. 2016;17(6):891. doi:10.3390/ijms17060891
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Deliv Rev. 2011;63(3):136–151. doi:10.1016/j.addr.2010.04.009
   PubMed Web of Science ®Google Scholar
• Maeda H, Fang J, Inutsuka T, et al. Vascular permeability enhancement in solid tumor: various factors, mechanisms involved and its implications. Int Immunopharmacol. 2003;3(3):319–328. doi:10.1016/S1567-5769(02)00271-0
   PubMed Web of Science ®Google Scholar
• Chen C, Wang Y, Tang Y, et al. Bifidobacterium-mediated high-intensity focused ultrasound for solid tumor therapy: comparison of two nanoparticle delivery methods. Int J Hyperthermia. 2020;37(1):870–878. doi:10.1080/02656736.2020.1791365
   PubMed Web of Science ®Google Scholar
• Liu Y, Li J, Chen H, et al. Magnet-activatable nanoliposomes as intracellular bubble microreactors to enhance drug delivery efficacy and burst cancer cells. Nanoscale. 2019;11(40):18854–18865. doi:10.1039/C9NR07021D
   PubMed Web of Science ®Google Scholar
• Wang D, Jiang F, Wang L, et al. Polyethylenimine (PEI)-modified poly (lactic-co-glycolic) acid (PLGA) nanoparticles conjugated with tumor-homing bacteria facilitate high intensity focused ultrasound-mediated tumor ablation. Biochem Biophys Res Commun. 2021;571:104–109. doi:10.1016/j.bbrc.2021.07.061
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Chen P, et al. Enzyme-instructed self-aggregation of Fe3O4 nanoparticles for enhanced MRI T2 imaging and photothermal therapy of tumors. Nanoscale. 2020;12(3):1886–1893. doi:10.1039/C9NR09235H
   PubMed Web of Science ®Google Scholar
• Liang X, Chen M, Bhattarai P, et al. Complementing cancer photodynamic therapy with ferroptosis through iron oxide loaded porphyrin-grafted lipid nanoparticles. ACS Nano. 2021;15(12):20164–20180. doi:10.1021/acsnano.1c08108
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen H, Shi J. Nanobiotechnology promotes noninvasive high-intensity focused ultrasound cancer surgery. Adv Healthc Mater. 2015;4(1):158–165. doi:10.1002/adhm.201400127
   PubMed Web of Science ®Google Scholar
• Luo W, Zhou X, Zhang J, et al. Analysis of apoptosis and cell proliferation after high intensity-focused ultrasound ablation combined with microbubbles in rabbit livers. Eur J Gastroenterol Hepatol. 2007;19(11):158–165. doi:10.1097/MEG.0b013e3282cfb6f0
   Web of Science ®Google Scholar
• Li X, Fu GF, Fan YR, et al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Ther. 2003;10(2):105–111. doi:10.1038/sj.cgt.7700530
   PubMed Web of Science ®Google Scholar
• Kimura NT, Taniguchi S, Aoki K, et al. Selective localization and growth of Bifidobacterium bifidum in mouse tumors following intravenous administration. Cancer Res. 1980;40(6):2061–2068.
   PubMed Web of Science ®Google Scholar
• Cai W, Chen X. Multimodality molecular imaging of tumor angiogenesis. J nuclear med. 2008;Suppl 49(Suppl 2):113s–128s. doi:10.2967/jnumed.107.045922
   Web of Science ®Google Scholar
• Kim J, Choi W, Park EY, et al. Real-time photoacoustic thermometry combined with clinical ultrasound imaging and high-intensity focused ultrasound. IEEE Trans Biomed Eng. 2019;66(12):3330–3338. doi:10.1109/TBME.2019.2904087
   PubMed Web of Science ®Google Scholar